Is cardiorespiratory regulation affected by perinatal cannabinoid exposure?

Research Opportunity
Master of Biomedical Science
Number of Master Places Available
1
Primary Supervisor Email Number Webpage
Dr Makhala Khammy mmkhammy@unimelb.edu.au Personal web page
Co-supervisor Email Number Webpage
Dr Mariana Melo
Dr Aung Aung Kywe Moe

Summary The Cardiovascular Therapeutics Unit has research interests across diverse areas of cardiovascular and autonomic pharmacology. Research areas include cannabinoid pharmacology in the vasculature and roles in the autonomic and sensory nervous systems, endothelin pharmacology in the setting of pulmonary hypertension, snake venom toxinology and vascular reactivity in hypertension.

Project Details

The Cardiovascular Therapeutics Unit has research interests across diverse areas of cardiovascular and autonomic pharmacology. Research areas include cannabinoid pharmacology in the vasculature and roles in the autonomic and sensory nervous systems, endothelin pharmacology in the setting of pulmonary hypertension, snake venom toxinology and vascular reactivity in hypertension.  

Cannabis is the most widely consumed illicit drug in Australia and globally, even amongst pregnant women. As social attitudes towards cannabis use shift towards perceived harmlessness, the prevalence of cannabis use in pregnant women is expected to increase. Thus, research on the effects of cannabis exposure during pregnancy on the offspring is urgently needed.  




Research Opportunities

Master of Biomedical Science
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research

Graduate Research application

Honours application

Key Contact

For further information about this research, please contact a supervisor.


MDHS Research library
Explore by researcher, school, project or topic.